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Summary
Background: MST1 and MST2 are the mammalian Ste20-
related protein kinases most closely related to Drosophila
Hippo, a major regulator of cell proliferation and survival
during development. Overexpression of MST1 or MST2 in
mammalian cells is proapototic; however, little is known
concerning the physiologic regulation of the endogenous
MST1/MST2 kinases, their role in mammalian cell proliferation,
or the identity of the MST1/MST2 substrates critical to prolifer-
ative regulation.
Results: We show that MST1 and MST2 activity increases
during mitosis, especially in nocodazole-arrested mitotic cells,
where these kinases exhibit both an increase in both abun-
dance and activation. MST1 and MST2 also can be activated
nonphysiologically by okadaic acid or H2O2. The MOBKL1A
and MOBKL1B polypeptides, homologs of the Drosophila
MATS polypeptide, are identified as preferred MST1/MST2
substrates in vitro and are phosphorylated in cells in an
MST1/MST2-dependent manner in mitosis and in response
to okadaic acid or H2O2. MST1/MST2-catalyzed MOBKL1A/
MOBKL1B phosphorylation alters the ability of MOBKL1A/
MOBKL1B to bind and regulate downstream targets such as
the NDR-family protein kinases. Thus, MOBKL1A/MOBKL1B
phosphorylation in cells promotes MOBKL1A/MOBKL1B
binding to the LATS1 kinase and enables H2O2-stimulated
LATS1 activation loop phosphorylation. Most importantly,
replacement of endogenous MOBKL1A/MOBKL1B by a
nonphosphorylatable mutant is sufficient to accelerate cell
proliferation substantially by speeding progression through
G1/S as well as mitotic exit.
Conclusions: These results establish that MST1 and MST2 are
activated in mitosis and catalyze the mitotic phosphorylation
of MOBKL1A/MOBKL1B. MOBKL1A/MOBKL1B phosphoryla-
tion, in turn, is sufficient to inhibit proliferation through actions
at several points in the cell cycle.
Introduction
MST1 (stk4) and MST2 (stk3) are class II GC kinases [1], initially
identified by their Ste20-related catalytic domain [2] and
independently as KRS1 and KRS2, protein kinases activated
late after transformation by v-src [3]. The regulation and
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are not completely understood. Early studies showed that
overexpression of MST1 or MST2 in mammalian cells
promotes apoptosis; in addition, apoptosis, once initiated by
a variety of stimuli, results in the activation of MST1/MST2,
and a caspase-catalyzed cleavage generates a highly active
catalytic fragment [4–6]. MST1 also can be activated in cells
by okadaic acid, H2O2, or heat shock at 55
C. A more physio-
logic activation of MST1 is reflected by the requirement for
a Nore1B/RAPL-MST1 complex in the rap1-induced increase
in integrin avidity that occurs in response to TCR or chemokine
stimulation of murine T cells [7], although the MST1 substrates
responsible for this action are as yet unknown.
MST1 and MST2 are the closest mammalian orthologs of the
Drosophila Hippo protein kinase (for reviews, see [8–10]), and
human MST2 (but not MST1) can complement Hippo
deficiency in the fly [11]. Hippo deficiency in the developing
eye results in massive overgrowth due to an accelerated rate
of proliferation and a failure of developmental apoptosis. The
phenotype of Hippo deficiency is very similar to that seen
with loss of function (LOF) of Warts/LATS, another protein
kinase. Warts is orthologous to the murine LATS1 kinase,
and biallelic deletion of the murine LATS1 gene results in soft
tissue sarcomas and ovarian tumors [12]. The noncatalytic
protein Salvador/Shar-pei, whose deficiency results in a phe-
notype resembling a weak LOF of both Hippo and Warts/
LATS, binds to both kinases, and is believed to facilitate
Hippo-catalyzed phosphorylation and activation of Warts/
LATS. In turn, Warts/LATS phosphorylates and inhibits the
transcriptional regulator Yorkie, whose overexpression
phenocopies the LOF of Hippo and Warts/LATS [13]. LOF of
the Drosophila MATS gene yields a phenotype closely resem-
bling those of Hippo and Warts/LATS [14]; MATS is homolo-
gous to the S. cerevisae polypeptides Mob1 and Mob2,
which act during mitotic exit to facilitate the ability of Cdc15,
a Hippo/MST1-2 homolog, to phosphorylate and activate
Dbf2, a Warts/LATS-like protein kinase (see [15, 16] for review).
Wei et al. found that MATS is a Hippo substrate that serves
a similar role in the Hippo activation of Warts/LATS [17]. In
turn, recent evidence indicates that mammalian MST2 can
phosphorylate and activate LATS1 [18] and that the LATS1
and LATS2 kinases also may regulate mitotic exit [19, 20].
Other candidate MST substrates are histone H2B, which is
phosphorylated at Ser14 during apoptosis, possibly by a
caspase-cleaved catalytic fragment of MST1 [21]; and
the FoxO1 and 3 polypeptides, whose MST1-catalyzed
phosphorylation interferes with negative regulation of FoxO
by Akt [22].
Thus, kinases orthologous with MST1 and MST2 appear to
contribute to a variety of cellular programs, including mitotic
progression, integrin affinity, apoptosis, and tumor suppres-
sion. Herein we identify the MOBKL1A/MOBKL1B polypep-
tides as major physiologic substrates of MST1/MST2 and
characterize the effects of this phosphorylation on
MOBKL1A/MOBKL1B binding to NDR-family kinases. Impor-
tantly, we demonstrate that the MST1/MST2-catalyzed
phosphorylation of MOBKL1A/MOBKL1B in intact cells is
sufficient to substantially retard cell-cycle progression.
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(A) Shown is the detection of an MST1 substrate in vitro. L1210 cell extract was fractionated by NaCl gradient elution. Fractions were subjected to
phosphorylation 6 MST1 as described in the Supplemental Experimental Procedures.
(B) Time course of MST1-catalyzed 32P incorporation into MOBKL1A (-), histone H2B (:), and Peroxiredoxin-1 (Prx-1) (>).
(C) The effect of mutation of MOBKL1A Thr12 and Thr35 on MOBKL1A phosphorylation by MST1.
(D) Different MOB family members as substrates for MST1/MST2/MST3. Substrates were phosphorylated by preactivated MST1 (solid lines), MST2 (dashed
lines), and MST3 as in (B) for the time points indicated. The insert shows a Coomassie blue stain reflecting the relative amount of the substrates in the
reaction. The open symbols are MST1, and the closed symbols are MST2. The panel below the graph is an anti-FLAG blot reflecting the relative amount
of each kinase in the reaction. The autoradiograph shows the relative amount of 32P incorporation into the kinases and the substrates.Results
Screening for MST1 Substrates In Vitro
Extracts of murine L1210 preB-cell leukemia cells (ATCC
CCL219) were fractionated on anion and cation exchange
columns, and fractions were briefly phosphorylated in vitro
[23] with recombinant MST1, which had been preactivated in
vitro by incubation with Mg + ATP [24]. The most prominent
MST1-phosphorylated band was a polypeptide of approxi-
mately 25 kDa recovered in the eluate of the cation exchange
column (Figure 1A). Gel filtration of the pooled fractions
containing this putative substrate resulted in a large portion
emerging just behind the void volume, Mr > 500 kDa, with
the remainder eluting at a molecular weight of approximately30 kDa. The latter peak was pooled and subjected to
SDS-PAGE, and the polypeptides migrating between Mr
20–40 kDa were digested in situ with trypsin; the tryptic
peptides were analyzed by ESI-MS-MS. The largest number
of peptides identified corresponded to peroxyredoxin1;
however, a substantial number of peptides corresponded to
MOBKL1A and MOBKL1B, mammalian homologs of the yeast
Mob and Drosophila MATS polypeptides. The mouse and
human genomes each contain two genes encoding MATS-
related polypeptides that are identical between the two
species and that differ from each other at only 8/216 amino
acids (96.3% identity); the human polypeptide described by
NP_775739 is MOBKL1A (encoded on Chr 4q13.3), and the
human polypeptide described by NP_060691 is MOBKL1B
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313(encoded on Chr 2p13.1); the tryptic peptides we retrieved did
not distinguish between MOBKL1A and MOBKL1B; MATS is
almost 90% identical to both.
MOBKL1A and MOBKL1B Are Selectively Phosphorylated
by MST1 and MST2 In Vitro
We examined comparable concentrations of recombinant
peroxyredoxin1, MOBKL1A, and histone H2B as potential in
vitro substrates for the MST1 kinase. As seen in Figure 1B,
MOBKL1A is phosphorylated at a rate 10-fold (or more) faster
than is H2B and it rapidly reaches nearly 1 mol PO4 incorpora-
tion/mol MOBKL1A polypeptide (Figure 1B), whereas peroxyre-
doxin 1 is not phosphorylated. MOBKL1A phosphorylated by
MST1 to approximately 0.3 mol PO4/mol was subjected to
tryptic digestion, and phosphopeptides were identified and
sequenced by MS-MS; two tryptic phosphopeptides were re-
trieved and found to be phosphorylated at Thr12 and Thr35.
These MOBKL1A threonine residues were converted to alanine
singly and together; mutation of each threonine substantially
reduced the extent of 32P incorporation into MOBKL1A, and
MOBKL1A (Thr12Ala/Thr35Ala) was phosphorylated at <5%
the rate and extent as wild-type MOBKL1A (Figure 1C). We
also examined the ability of recombinant preactivated
FLAG-MST1, -MST2, and -MST3, each at comparable poly-
peptide concentrations, to phosphorylate mammalian
recombinant MOBKL1A, MOBKL1B, MOBKL2B, and MOB2/
HCCA2 (Figure S1 available online), all at identical concentra-
tions (Figure 1D). MOBKL1B was phosphorylated at the
highest rate, approximately 2-fold faster than MOBKL1A and
9- to 14-fold faster than MOBKL2B; MOB2/HCCA2 was not
phosphorylated at all. The MST1, MST2, and MST3 polypep-
tides each were preactivated by incubation in vitro with Mg +
ATP and added at identical polypeptide concentrations; under
these conditions, MST2 catalyzed phosphorylation at approx-
imately twice the rate of MST1, whereas MST3, although capa-
ble of autophosphorylation to an extent approximately half that
of MST1 and MST2, does not phosphorylate any of these
Mob-related polypeptides. Thus MOBKL1A and MOBKL1B
are selective substrates of the MST1 and MST2 kinases.
MOBKL1 Binds Activated MST2 Preferentially, and
MOBKL1 Phosphorylation Inhibits the Binding of MST2
Overexpressed recombinant MOBKL1A coprecipitates endog-
enous MST1, MST2, LATS1, LATS2 (Figure S2A), and NDR1
(identified by MS/MS, data not shown) from HEK293T cells.
Recombinant MOBKL1B binds coexpressed MST2 much
better than MST1; however, the inactive MST2 mutant K56R
binds MOBKL1B much more poorly than wild-type MST2
(Figure 2A); this suggests that activated MST2 may bind
MOBKL1B much better than the inactive kinase. We showed
previously [24] that when transiently expressed in HEK293T
cells, MST1 and MST2 are retrieved predominantly in an unac-
tivated state but can be fully activated by pretreatement of cells
with okadaic acid or in vitro by autophosphorylation. We there-
fore compared the ability of MST2 to bind in vitro to prokaryotic
recombinant MOBKL1A polypeptides, with or without in vitro
autophosphorylation/preactivation of MST2 (Figure 2B, lanes
2–7). Autophosphorylated, preactivated MST2 binds
MOBKL1A wild-type and MOBKL1A (Thr12/35Ala) comparably
(Figure 2B, compare lanes 5 and 6) and much better than
unactivated MST2 (Figure 2B compare lanes 2 and 3 to lanes
5 and 6). If Mg++ and ATP are included in the incubation of
MST2 with the MOBKL1A wild-type and Thr12/Thr35 polypep-
tides, then concomitant with the phosphorylation of wild-typeMOBKL1A, its ability to bind MST2 is greatly diminished
(Figure 2B, compare lane 5 to lane 12), whereas the ability of
MST2 to bind to MOBKL1A (Thr12/35Ala) is unaffected by the
presence of Mg++ and ATP (Figure 2B, compare lane 6 to lane
13). The results indicate that MST2 (and probably MST1)
must be activated to bind MOBKL1A. Moreover, once phos-
phorylated by MST2, the ability of MOBKL1A to bind MST2 is
greatly diminished.
MOBKL1 Phosphorylation Enhances Its Binding
of LATS1 and NDR1
The NDR kinases, such as the mammalian LATS1/LATS2 and
NDR1/NDR2 are AGC-family kinases that are activated by
phosphorylation at two regulatory sites, one in a hydrophobic
motif located carboxy-terminal to the canonical catalytic
domain, and a second in the activation loop of the catalytic
domain (see [25] for review). An upstream kinase is required
for phosphorylation of the carboxy-terminal site, whereas
most evidence indicates that the activation loop phosphoryla-
tion is an autophosphorylation [26–28]. In Drosophila, the
Hippo kinase was shown to phosphorylate and activate the
Warts/LATS kinase, and one of the six Drosophila Mob
homologs (i.e., MATS) was shown to bind Warts/LATS and
potentiate its activation; moreover loss of MATS yielded an
overgrowth phenotype similar to that seen with loss of Hippo
or Warts/LATS [14]. MOBKL1A/MOBKL1B can bind to
LATS1/LATS2 (Figure 2C and Figures S2A and S2B) and to
NDR1 (Figure S2B), and Bischel et al. [29] reported that oka-
daic acid treatment prior to extraction of Mob1 greatly in-
creased the ability of recombinant Mob1 to bind NDR1 in vitro.
Moreover, Mob1 binds to an amino-terminal segment of NDR1
and is accompanied by kinase activation, presumably due to
release from an intramolecular autoinhibition. We find that
MST2-catalyzed phosphorylation of MOBKL1A strongly en-
hances the binding of LATS1 (Figure 2C). Mutation of Thr12
to alanine modestly diminishes LATS1 binding, whereas muta-
tion of Thr35 has a much stronger inhibitory effect (Figure S2B),
and conversion of both threonines to alanines nearly elimi-
nates LATS1 binding (Figure 2C). MST2-phosphorylated MOB-
KL1A binds LATS1 isolated from control or okadaic-acid-
treated cells to a similar extent (Figure 2C). Mutation of
Thr12/Thr35 to Glu does not mimic the effect of MOBKL1A/
MOBKL1B phosphorylation but, rather, alters MOBKL1A bind-
ing to MST2 and LATS1 in a manner similar to the MOBKL1A
Thr12/35Ala mutations (data not shown). MST2-catalyzed
MOBKL1A phosphorylation also enhances the binding in vitro
of NDR1 (Figure S2B). The operation of these effects in the in-
tact cell is illustrated in Figure 2D; thus whereas okadaic acid
pretreatment enhances the ability of recombinant wild-type
MOBKL1A to bind endogenous LATS1, okadaic acid pretreat-
ment does not enable the binding of LATS1 to MOBKL1A
(Thr12/35Ala); with regard to MST1/MST2, okadaic acid
pretreatment enhances the binding of endogenous MST1
and MST2 to MOBKL1A (Thr12/35Ala) much more than to
wild-type MOBKL1A, presumably reflecting the ability of
okadaic acid to promote MST1/MST2 activation, together
with the inability of the mutant MOBKL1A to be phosphory-
lated, which would inhibit its ability to bind MST1/MST2.
MST1/MST2 Mediates MOBKL1A/MOBKL1B and LATS1
(Thr1079) Phosphorylation in Response to Okadaic Acid
and H2O2 in Intact Cells
Little is known concerning the physiologic regulation of MST1
or MST2. Nevertheless, MST1/MST2 can be activated by
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314Figure 2. Characterization of MOBKL1A/MOBKL1B Binding to MST1/MST2 and LATS1
(A) MOBKL1B binds native MST2 in preference to kinase-dead MST2 or native MST1. HA-MOBKL1B was cotrasfected in HEK293T cells with the Flag-tagged
MST1 and MST2 variants indicated.
(B) MST2 autophosphorylation enhances, whereas MST2-catalyzed MOBKL1A phosphorylation inhibits, the MST-MOBKL1A interaction in vitro. Immobi-
lized GST (lanes 4, 7, 11, and 14), GST-MOBKL1A wild-type (lanes 3, 6, 10, and 13), and the GST-MOBKL1A (Thr12/35Ala) (lanes 2, 5, 9, and 12) were incu-
bated with purified MST2, nonpreactivated (lanes 2–4 and 9–11), or preactivated (lanes 5–7 and 12–14), with (lanes 9–14) or without (lanes 2–7) ATP. Note that
phosphorylation of MOBKL1A (lanes 9 and 12) reduces its reactivity with the anti-MOBKL1A/MOBKL1B antibody (lowest panel).
(C) Characterization of LATS1 binding to unphosphorylated and phosphorylated MOBKL1A in vitro is shown. Immobilized GST, GST-MOB1A wild-type, or
GST-MOBKL1A (Thr12/35Ala) were preincubated with preactivated MST2, with (lanes 7-12) or without (lanes 1–6) MgCl2 and ATP. After washing, okadaic-
acid-treated (lanes 2, 4, 6, 8, 10, and 12) or untreated (1, 3, 5, 7, 9, and 11) HEK293T cell lysates containing Flag-LATS1were added for pull-down assay.
(D) Characterization of the effect of okadaic acid on the ability of recombinant MOBKL1A wild-type or MOBKL1A (Thr12/35Ala) to bind endogenous
MST1/MST2 and LATS1 during transient expression is shown. HEK293T cells expressing FLAG-tagged MOBKL1A wild-type (lanes 1 and 2) or MOBKL1A
(Thr12/T35Ala) (lanes 3 and 4) were treated with okadaic acid (OA) (lanes 2 and 4) or not (lanes 1 and 3). Aliquots of the cell extracts containing 2 mg protein
were incubated with either okadaic acid (lanes 2 and 4) or alkaline phosphatase (lanes 1 and 3) at room temperature for 30 min. and then subjected to anti-
Flag immunoprecipitation.incubation of cells with okadaic acid or by subjecting cells to
certain severe stressors such as H2O2 [3, 24]. Under these
conditions, the phosphorylation of MST1 and MST2 in their
activation loop at Thr183 and Thr180, respectively, is in-
creased (Figures 3A and 3B, fourth row from top) and MOB-
KL1A/B phosphorylation at both Thr12 and Thr35 is markedly
increased (Figures 3A and 3B, top two rows). To probe the role
of MST1/MST2 in these phosphorylations, we selected stable
U2OS transformants that overexpress either a wild-type or a
kinase-dead mutant of Flag-MST2 in a tetracycline-responsive
manner. The recombinant inactive Flag-MST2, through its car-
boxy-terminal SARAH domain, is capable of dimerizing with
endogenous full-length MST1 and MST2 [24]. Inasmuch as
MST1/MST2 activation requires transphosphorylation by the
dimer partner [24], the heterodimers of MST2 (K56R) with
endogenous MST1 or MST2 are inactive. Induction of MST2
(K56R) markedly inhibits the ability of okadaic acid to promote
MOBKL1A/MOBKL1B phosphorylation (Figure 3A, top two
rows) and blocks the okadaic-acid-induced increase
in LATS1 carboxy-terminal phosphorylation at Thr1079(Figure 3A, fourth row from bottom). Notably, okadaic-acid-
stimulated phosphorylation of the LATS1 activation loop at
Ser909, thought to be an autophosphorylation, is not affected
by overexpression of MST2 (K56R) (Figure 3A, third row from
bottom). Validation of the specificity of the MOBKL1A/
MOBKL1B and LATS1/LATS2 phosphospecific antibodies is
provided in Figure S3.
H2O2 is a strong activator of endogenous MST1/MST2 and
also results in robust MOBKL1A/MOBKL1B phosphorylation;
induction of MST2 (K56R) markedly inhibits H2O2-induced
MOBKL1A/MOBKL1B phosphorylation (Figure 3B, top two
rows). The MST2 (K56R) also inhibits the H2O2-induced phos-
phorylation of the LATS1 carboxy-terminal site and results in
a partial inhibition of LATS1 activation loop phosphorylation.
Overexpression of MST2 (K56R) does not alter the H2O2-
induced phosphorylation of endogenous ERK or Jnk
(Figure S4A). Tetracycline-induced overexpression of wild-
type MST2 causes a pronounced increase in H2O2-stimulated
LATS1 (Thr1079) phosphorylation (Figure S4B, third row from
bottom) and a modest increase in the phosphorylation of
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315Figure 3. The Role of MST1/MST2 in MOBKL1A/MOBKL1B and LATS1 Phosphorylation in Response to Okadaic Acid and H2O2
(A) Overexpression of a kinase-dead MST2 inhibits okadaic-acid-induced MOBKL1A/MOBKL1B and LATS1/LATS2 (Thr1079), but not LATS1/LATS2
(Ser909) phosphorylation. U2OS cells stably expressing a tetracycline (Tet) inducible Flag-MST2 (K56R) were treated with doxycycline (lanes 3 and 4) or
carrier (lanes 1 and 2) and 12 hr later with okadaic acid (1 mM) (lanes 2 and 4) or carrier (lanes 1 and 3) for 30 min prior to harvest.
(B) Overexpression of a kinase-dead MST2 inhibits H2O2-induced MOBKL1A/MOBKL1B and phosphorylation of both LATS1/LATS2 (Thr1079) and LATS1
(Ser909). The experiment was carried out exactly as in (A), except the stimulation was with H2O2 (2.5 mM), which was added for 20 min.
(C) Replacement of endogenous MOBKL1A/MOBKL1B with recombinant MOBKL1A wild-type does not alter H2O2 stimulated LATS1/LATS2 phosphoryla-
tion. U2OS cells carry cassettes of shRNA against 30 UTR of MOBKL1A, shRNA directed against the coding region of MOBKL1B, and cDNA encoding Flag-
MOBKL1A. The first cassette is constitutively expressed, whereas the latter two are tetracycline inducible. Five days prior to stimulation, doxycycline (5 mg/
ml) (lanes 3 and 4) or carrier (lanes 1 and 2) was added. Cells were treated with H2O2 as in (B) (lanes 2 and 4). Note that the recombinant Flag-MOBKL1A runs
slightly slower than the endogenous MOBKLIA/MOBKL1B.
(D) Elimination of endogenous MOBKL1A/MOBKL1B phosphorylation selectively eliminates H2O2-stimulated phosphorylation of LATS1/LATS2 (Ser909),
but not of LATS1/LATS2 (Thr1079). The experiment was carried out exactly as in (C), except that the cDNA sequences employed encodes MOBKL1A
(Thr12/35Ala).endogenous MOBKL1A/MOBKL1B and in LATS1 (Ser909)
phosphorylation. Together, these data provide strong
evidence that MST1/MST2 are the kinases responsible for
the okadaic-acid- and H2O2-stimulated phosphorylation of
MOBKL1A/MOBKL1B and LATS1 (Thr1079).
MST1/MST2-Stimulated MOBKL1A/MOBKL1B
Phosphorylation Is Required for H2O2-Stimulated
LATS1 (Ser909) Phosphorylation
In the presence of okadaic acid, LATS1 (Ser909) activation
loop phosphorylation persists in the presence of MST2
(K56R) despite inhibition of LATS1 (Thr1079) and MOBKL1A/
MOBKL1B phosphorylation (Figure 3A), consistent with the
view that LATS1 (Ser909) phosphorylation is catalyzed by an
intramolecular autophosphorylation rather than by MST1/
MST2. Nevertheless, the observation that overexpressed
MST2 (K56R) inhibits H2O2-stimulated LATS1 (Ser909)phosphorylation (Figure 3B) impelled us to examine further
the significance of MOBKL1A/MOBKL1B phosphorylation for
LATS1 phosphorylation. For this purpose, we selected U2OS
cell lines that expressed, in a tetracycline-inducible manner,
shRNAs directed at endogenous MOBKL1A and MOBKL1B,
as well as the MOBKL1A wild-type (Figure 3C) or MOBKL1A
(Thr12/35Ala) (Figure 3D) polypeptides. Tetracycline induction
virtually eliminated expression of the endogenous MOBKL1A/
MOBKL1B polypeptides while greatly increasing the abun-
dance of the recombinant MOBKL1A polypeptides, which
exhibit a slightly slower electrophoretic mobility (Figures 3C
and 3D, second row from top). The recombinant wild-type
MOBKL1A polypeptide, like the endogenous, exhibits H2O2-
stimulated phosphorylation (Figure 3C, top row, lanes 3 and
4), whereas no MOBKL1A phosphorylation is detectable in
the cells expressing recombinant MOBKL1A (Thr12/35Ala)
(Figure 3D, top row, lanes 3 and 4), indicating that the
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and replaced by recombinant MOBKL1A (Thr12/35Ala).
Whereas tetracycline-induced replacement of endogenous
MOBKL1A/MOBKL1B by recombinant overexpressed wild-
type MOBKL1A does not significantly affect H2O2-stimulated
phosphorylation of LATS1 (Ser909) (Figure 3C, fifth row from
top, compare lanes 3 and 4 to lanes 1 and 2), replacement of
endogenous MOBKL1A/MOBKL1B by recombinant overex-
pressed MOBKL1A (Thr12/35Ala) inhibits H2O2-stimulated
phosphorylation of LATS1 (Ser909) (Figure 3D, fifth row from
top, compare lanes 3 and 4 to lanes 1 and 2). In contrast,
replacement of endogenous MOBKL1A/MOBKL1B by either
recombinant MOBKL1A wild-type or MOBKL1A (Thr12/35Ala)
does not alter H2O2-stimulated MST1/MST2 activation loop
phosphorylation, (Figures 3C and 3D, third row from top),
H2O2-stimulated LATS1/LATS2 (Thr1079) phosphorylation
(Figures 3C and 3D, fourth row from top), or LATS1 polypeptide
levels (Figures 3C and 3D, bottom row). These results indicate
that phosphorylated MOBKL1A promotes LATS1 (Ser909)
activation loop autophosphorylation in response to H2O2.
MST1 and MST2 Are Activated in Mitosis and Catalyze
the Mitotic Phosphorylation of MOBKL1A/MOBKL1B
and the LATS1 (Thr1079)
Although the yeast kinases most closely related to MST1/
MSTT2, Cdc15p in S. cerevisiae and cdc7 and Sid1p in
S. pombe, are known cell-cycle components necessary for
mitotic exit and cytokinesis, respectively, little or no informa-
tion is available concerning the state of MST1, MST2, or
mammalian MOBKL1A/MOBKL1B in mitosis. We therefore
characterized the abundance and activity of the MST1/MST2
kinases in mitosis in U2OS cells. Rapidly growing, unsynchro-
nized U2OS cells were extracted directly or after mitotic arrest,
obtained by shake-off after incubation overnight with nocoda-
zole; in addition, nocodazole-arrested mitotic cells were
washed free of the agent and replated, and extracts were pre-
pared at intervals thereafter (Figure 4A). As expected, cyclin B
abundance is substantially increased in the nocodazole-
arrested cells and declines rapidly after nocodazole washout
(Figure 4A, third row from bottom); reciprocally, the robust
cdk1(Tyr15) phosphorylation seen in unsynchronized cells is
undetectable in the nocodazole-arrested cells (Figure 4A,
second row from bottom). Nocodazole arrest also is accompa-
nied by an increase in the abundance of both MST1 and MST2
in comparison to the levels detected in freely cycling cells
(Figure 4A, top two rows, and Figure 4B); moreover, the
abundance of MST1 and MST2 decline rapidly after nocoda-
zole washout, although levels somewhat greater than those
seen in cycling cells are still evident at 1 hr after washout
(Figure 4A). Activation of the MST1 and MST2 kinase activity
in vitro requires phosphorylation on the activation loop at
Thr180 and Thr183, respectively [24]. MST1/MST2 phosphory-
lation at these sites is increased in the nocodazole-arrested
cells; however, it is not possible to judge reliably whether
this is due entirely to the increase in MST1/MST2 polypeptide
abundance or whether MST1 and/or MST2 also is activated.
Activation can be obtained in vitro by incubation of immuno-
precipitated MST1/MST2 with relatively ‘‘high’’ levels of Mg
2 ATP (approximate EC50 ATPw50 mM) and can be monitored
quantitatively by brief assay under conditions that minimize
further autoactivation during assay (e.g., 2 min at 10 mM ATP)
[24]. Immunoprecipitates of MST1 and MST2 therefore were
prepared from cycling and nocodazole-arrested cells, and
the fractional activation of MST1 and MST2 was quantitatedby measuring kinase activity under nonactivating conditions
with and without Mg + ATP preactivation in vitro, as described
previously [24]. The absolute values from three experiments
are summarized in Figure 4B, and the fractional activation is
described in the legend. The MST1 kinase immunoprecipitated
from cycling cells exhibits approximately 10% maximal activa-
tion, whereas this increases to approximately 40% in the
nocodazole-arrested cells (Figure 4B, left; see figure legend).
MST2 exhibits w26% activation in cycling cells, which in-
creases to w45% in mitotic cells (Figure 4B, right; see figure
legend). The higher ‘‘basal’’ activation state of MST2, as com-
pared with MST1, was observed previously with transiently
expressed recombinant polypeptides [24]. The increase in
MST1/MST2 abundance in mitotic cells (estimated at w3
fold), together with the increased fractional activation of the
MST1/MST2 kinases, indicates that the available activity of
both isoforms increases approximately 6- to 12-fold during
mitosis. Nocodazole arrest of U2OS cells also is accompanied
by an increased MOBKL1A/MOBKL1B phosphorylation at
Thr12 and Thr35, LATS1 (Thr1079), and LATS1 (Ser909), which
decline during washout roughly in parallel to the decrease in
MST1/MST2 (Thr183/Thr180) phosphorylation (Figure 4C).
Nocodazole arrests cells at metaphase by disruption of the
spindle structure and, thus, activates the spindle checkpoint;
to determine whether MST1/MST2 activation occurs in the
course of a normal mitosis, we collected cells easily shaken
off plates of freely cycling cultures. The presence of robust his-
tone H3 (Ser10) phosphorylation in these cells, as compared to
freely cycling, adherent cells, provided an indicator that a
substantial fraction of the cells collected by shake-off were in
mitosis (Figure 4D, third row from top). These untreated mitotic
cells also show enhanced MOBKL1A/MOBKL1B (Thr35) phos-
phorylation (top row) and LATS1 (Thr1079) phosphorylation
(Figure 4D, fifth row from top), as compared to the nonmitotic
cells. Notably, however, the intensity of MOBKL1A/MOBKL1B
phosphorylation in untreated mitotic cells was less than 10%
that seen in nocodazole-arrested cells, and an increased phos-
phorylation of the LATS1/LATS2 activation loop (Figure 4D,
fourth row from top) was not observed, in contrast to nocoda-
zole-arrested cells (Figure 4C, top row), suggesting that noco-
dazole, presumably by activation of the spindle checkpoint,
contributes substantially to extent of MST1/MST2 activation
beyond that occurring in an unimpeded mitosis.
Tetracycline induction of MST2 (K56R) prior to shake-off of
unimpeded mitotic cells eliminated mitotic phosphorylation
of endogenous MOBKL1A/MOBKL1B and modestly reduced
LATS1/LATS2 (Thr1079) phosphorylation in the nonarrested
mitotic cells (Figure 4D, fifth row from top, compare lanes
3 and 4 to lanes 1 and 2) but did not alter the LATS1/LATS2
(Ser909P) immunoreactivity (Figure 4D, fourth row from top,
compare lanes 3 and 4 to lanes 1 and 2) These results indicate
that MST1 and/or MST2 is activated during a normal mitosis
and is responsible for the mitotic phosphorylation of
MOBKL1A/MOBKL1B. The inability of MST2 (K56R) to fully
inhibit LATS1 (Thr1079) phosphorylation may indicate that
phosphorylation of LATS1 (1079) requires lesser amounts of
active MST1/MST2 than does phosphorylation of MOBKL1A/
MOBKL1B or that another kinase is responsible, in part, for
the mitotic phosphorylation of LATS1/LATS2 (Thr1079). The
failure to observe an alteration in LATS1 (Ser909) phosphoryla-
tion in an unimpeded mitosis is qualified somewhat by the
broadening of the LATS1/LATS2 band in mitosis; however,
the LATS1/LATS2 (Thr1079P) immunoreactivity, although
broadened, is unmistakably increased in M (Figure 4D, fifth
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317Figure 4. MST1/MST2 Activity, MOBKL1A/MOBKL1B, and LATS1 Phosphorylation in Nocodazole-Arrested and Unimpeded Mitotic U2OS Cells
(A) The MST1 and MST2 kinases exhibit increased abundance in nocodazole-arrested mitotic cells. U2OS cells either were exponentially growing (cycling) or
were arrested in metaphase by nocodazole (0 hr) and then harvested 0.5 and 1 hr after washing.
(B) The MST1 and MST2 kinases show increased fractional activation in nocodazole-arrested cells. Top: Extracts from cycling (marked as ‘‘C’’) or nocoda-
zole (‘‘N’’)-arrested mitotic U2OS were analyzed by immunoblot for MST1 and MST2. Bottom: Immunoprecipitates of MST1 and MST2 were prepared from
the extracts of cycling and nocodazole-arrested U2OS cells shown in the top panels. The bar graphs show the MST activities from three independent MBP
kinase assays. The fractional activation (% maximal) in the cycling and nocodazole-arrested cells (n = 3) were as follows. MST1: cycling, 10.36 1.2; mitotic,
40.8 6 6.4 (p < 0.01); MST2, cycling 26.4 6 6.7; mitotic, 45.6 6 1.3 (p < 0.03).
(C) Characterization of the effect of nocodazole-induced mitotic arrest on the phosphorylation of MOBKL1A/MOBKL1B and LATS1/LATS2 is shown. U2OS
cells were treated as in (A).
(D) Overexpression of kinase-dead MST2 in unimpeded mitotic cells eliminates mitotic MOBKL1A/MOBKL1B phosphorylation, modestly reduces LATS1
(Thr1079P), and does not alter LATS (Ser909P). U2OS cells carrying a tetracycline-inducible kinase-dead MST2 (K56R) were treated with doxycycline
(1 mg/ml) (lanes 3 and 4) or carrier (lanes 1 and 2) 12 hr prior to a mitotic shake-off in the absence of nocodazole. Histone H3 (Ser10) phosphorylation marks
mitosis.row from top). The inability of overexpressed MST2 (K56R) to
inhibit LATS1/LATS2 (Ser909) phosphorylation in M, whereas
it effectively suppresses this phosphorylation in response to
H2O2, is a further indication that the LATS1/LATS2 regulation
in M is likely to involve kinases other than MST1/MST2.
In U2OS cells, stable expression of lentiviral-encoded
shRNA against MST2 also can inhibit nocodazole-induced
MOBKL1A/MOBKL1B and LATS1/LATS2 phosphorylation,
but it is observable only in clones in which the suppression
of MST2 expression exceeds 90% (Figure S5), a level of inhibi-
tion well beyond that achieved in unselected mixtures of cells
infected with the lentiviral-encoded shRNA or by using RNAi
oligonucleotides.Elimination of MOBKL1A/MOBKL1B Phosphorylation
Stimulates Cell Proliferation
The ability to replace endogenous MOBKL1A/MOBKL1B with
recombinant wild-type or mutant MOBKL1A (Figures 3C and
3D) enabled an examination of the effects of MOBKL1A/
MOBKL1B phosphorylation on cell proliferation. Replacement
of endogenous MOBKL1A/MOBKL1B with recombinant wild-
type MOBKL1A (Figure 5A, left) had no discernable affect on
proliferative rate (Figure 5B, left), whereas replacement with
MOBKL1A (Thr12/35Ala) (Figure 5A, right) increased prolifera-
tive rate by 2- to 3-fold (Figure 5B, right). Despite the enhanced
proliferative rate seen with MOBKL1A/MOBKL1B(Thr12/
35Ala), the distribution of the cells in various phases of the
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318Figure 5. Elimination of MST1/MST2-Catalyzed MOBKL1A/MOBKL1B Phosphorylation Accelerates U2OS Cell Proliferation
(A) Doxycycline-induced replacement of endogenous MOBKL1A/MOBKL1B with recombinant MOBKL1A wild-type or MOBKL1A (Thr12/35Ala) is shown.
U2OS cells described in Figures 3C and 3D were treated with doxycycline for 5 days and then replated at an appropriate density. Unimpeded mitotic cells
were collected as in Figure 4D. Note in the experiment illustrated on the left that the mitotic phosphorylation of the endogenous MOBKL1A/MOBKL1B poly-
peptides is greatly reduced after doxycycline induction, whereas the doxycycline-induced recombinant, overexpressed wild-type MOBKL1A is heavily
phosphorylated in mitosis. In the experiment illustrated on the right, endogenous MOBKL1A/MOBKL1B polypeptides and phosphorylation also are abol-
ished. The Thr35P immunoreactivity of the MOBKL1A (Thr12/35Ala) is indistinguishable in the cycling and shaken-off cells; this signal probably reflects the
very minor nonphosphospecific immunoreactivity of this antibody, uncovered by the marked overexpression of recombinant MOBKL1A (Thr12/35Ala).
(B) Elimination of MST1/MST2-catalyzed MOBKL1A/MOBKL1B phosphorylation accelerates U2OS cell proliferation. The doxycycline induction and the
replating was carried out exactly as described in (A). The cell counts at each day after replating are shown. The error bars represent the SEM. On the right,
the differences between Dox2 and Dox+ on days 3–6 are all significant at p < 0.01.cell cycle was not significantly altered by replacement of en-
dogenous MOBKL1A/MOBKL1B with either wild-type MOB-
KL1A or MOBKL1A (Thr12/35Ala) (Figure 6A) in the absence
or presence of doxycycline. This suggested that the stimula-
tory effect on proliferation of replacing endogenous MOB-
KL1A/MOBKL1B with a nonphosphorylatable MOBKL1A may
be due to actions exerted at several sites in the cell cycle.
We estimated the effect of MOBKL1A/MOBKL1B replacement
on the rate of progression through G1/S by examining the rate
at which cells accumulate in G2/M after addition of nocodazole
(Figure 6B). Twenty-four hours after addition of nocodazole,
the fraction of cells in G2/M had increased from 24.6% to
46.4% (a 21.8% increment) in one cell line and from 28.3% to
48.4% in a second cell line (a 20.1% increment). Doxycy-
cline-induced replacement of endogenous MOBKL1A/
MOBKL1B by wild-type MOBKL1A resulted in a slightly lesser
increase in progression to G2/M (24.9% to 43.4%, an 18.5%
increment). In contrast, replacement of endogenous
MOBKL1A/MOBKL1B by nonphosphorylatable MOBKL1A
greatly increased the fraction of cells that had progressed to
G2/M over the same interval, from 21.0% to 58.1% (a 37.1%
increment). This nearly 2-fold increase in the rate of passage
through G1/S into G2/M seen when MOBKL1A (Thr12/35Ala)
is overexpressed, as compared with wild-type MOBKL1A, is
likely to underlie a substantial component of the increasedrate of proliferation (Figure 5B) that results from replacement
of endogenous MOBKL1A/MOBKL1B with the nonphosphory-
latable MOBKL1A mutant. We also examined whether
MOBKL1A/MOBKL1B phosphorylation affects the rate of exit
from mitosis into G1 (Figures 6C and 6D). Elimination of endog-
enous MOBKL1A/MOBKL1B and its replacement with overex-
pressed, wild-type MOBKL1A causes a modest slowing in the
rate of entry from M into G1 (Figure 6C), whereas replacement
with MOBKL1A (Thr12/35Ala) results in an acceleration of
mitotic exit of a comparable extent (Figure 6D). These data
indicate that MOBKL1A/MOBKL1B phosphorylation by MST1
and/or MST2 delays mitotic exit.
Discussion
MOBKL1A/MOBKL1B Are Physiologic Substrates
of the MST1 and MST2 Kinases
The present data identify MOBKL1A and MOBKL1B as avid
and physiologic substrates of the MST1 and/or MST2 kinases.
MST2 activation enables its binding to MOBKL1A/MOBKL1B,
and MST2-catalyzed MOBKL1A/MOKL1B phosphorylation
inhibits MST2 binding while enhancing MOBKL1A/MOBKL1B
binding of LATS1 (and NDR1); consequently it is likely that
MOBKL1A/MOBKL1B binding to MST2 and LATS1 is sequen-
tial. Moreover, the ability of overexpressed MST2 (K56R) to
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319Figure 6. Elimination of MOBKL1A Phosphorylation Accelerates Progression through G1/S and Mitotic Exit
(A and B) Elimination of MOBKL1A phosphorylation accelerates progression through G1/S. The U2OS cells were treated with doxycycline and replated
exactly as described in Figure 5A. (A) Three days after replating, aliquots of the cells were subjected to DNA content analysis by FACS. Note that when
growing exponentially in the absence of nocodazole, neither cell line shows significant effects of doxycycline on cell-cycle distribution. (B) A parallel
set of cells were treated with nocodazole, harvested 24 hr later, and analyzed for DNA content by FACS. Note that replacement with MOBKL1A
(Thr12/35Ala) is accompanied by fewer cells in G1 and more in G2/M.
(C and D) Elimination of MOBKL1A phosphorylation accelerates exit from mitosis into G1. Doxycycline, replating, and nocodazole treatments were
performed as in (A) and (B). Cells arrested in mitosis (4N) were then collected by shake-off. A portion of mitotic cells were washed free of nocodazole
and replated. The cells expressing MOBKL1A wild-type (C) were harvested 2 hr after replating, whereas the cells expressing MOBKL1A (Thr12/35Ala) (D)
were harvested 3.5 hr after replating. Cells are analyzed by FACS (lower FACS scans) The fraction of replated cells exhibiting 2N DNA content is shown below
the FACS scans and reflects the fraction of cells exiting mitosis into G1. Note that replacement of endogenous MOBKL1A/MOBKL1B with recombinant
MOBKL1A wild-type diminishes the fraction of cells exiting M, whereas replacement with MOBKL1A (Thr12/35Ala) increases the fraction of cells exiting
M into G1.strongly inhibit MOBKL1A/MOBKL1B phosphorylation in
response to okadaic acid and H2O2, treatments known to acti-
vate a wide variety of protein kinases, indicates that MST1/
MST2 are the dominant—perhaps the only—kinases responsi-
ble for MOBKL1A/MOBKL1B phosphorylation in vivo. MST2
(K56R) also will bind through its SARAH domain to the
RASSF1-6 polypeptides and to WW45; we have not examined
the role of these polypeptides in MOBKL1A/MOBKL1B phos-
phorylation; however, the ability of MST2-directed shRNA,
when accompanied by >90% suppression of MST2 polypep-
tide expression, to inhibit nocodazole-induced MOBKL1A/
MOBKL1B phosphorylation (Figure S5) provides further
support for the primary role of MST1/MST2.
MST1/MST2 and MOBKL1A/MOBKL1B Regulate
LATS1/LATS2 by Multiple Mechanisms
Previous genetic and biochemical evidence has shown that
MST2 and its orthologs are required for the phosphorylation
and activation of LATS1 and orthologs ([25]; reviewed in
[8–10]). The ability of MST2 (K56R) overexpression to inhibitLATS1 (Thr1079) phosphorylation in response to okadaic acid
(Figure 4A) provides strong evidence in support of the earlier
suggestion that MST1 and/or MST2 is/are the kinase(s) respon-
sible for this phosphorylation in vivo. By contrast, LATS1 (909)
phosphorylation in response to okadaic acid is unaffected by
MST2 (K56R) overexpression, a finding compatible with the
view that the latter is an intramolecular autophosphorylation.
In response to H2O2, however, the phosphorylation of both
LATS1 (Thr1079) and LATS1 (Ser909) is strongly suppressed
by MST2 (K56R) (Figure 3B), indicating that with this stimulus,
MST1/MST2, probably through the generation of phospho-
MOBKL1A/MOBKL1B (Figures 3C and 3D), also is crucial for
LATS1 (Ser909) phosphorylation. Thus, MST1/MST2 promotes
LATS1 multisite phosphorylation through two parallel, inde-
pendent mechanisms: by direct phosphorylation at Thr1079
and by provision of phospho-MOBKL1A, which promotes
LATS1 autophosphorylation at Ser909 in vivo. In addition,
others have shown that MOBKL1A/MOBKL1B polypeptides
may determine the subcellular localization of LATS1-related
kinases [27, 30–32]. The importance of MOBKL1A/MOBKL1B
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320phosphorylation for MOBKL1A cellular localization is not yet
known. Phosphorylated MOBKL1A also binds NDR1 in vitro
(Figure S2B) and, during transient expression, however, previ-
ous work in S. cerevisae and mammalian cells suggests that
members of the MOBKL2A/MOBKL1B/MOBKL1C polypep-
tides are more likely to be the physiologic partners of the
NDR1/NDR2-kinase subfamily [25]. Stegert, et al. [33] reported
that MST3 can phosphorylate the NDR1 carboxy-terminal
hydrophobic site; however, we were unable to detect MST3-
catalyzed MOBKL1 or MOBKL2 phosphorylation in vitro
(Figure 1D); thus more work on the phosphorylation of the
MOBKL2 polypeptides and their relation to NDR1/NDR2
activation will be required.
MOBKL1A/MOBKL1B Phosphorylation Regulates
Cell Proliferation
The present data establish that MST1 and MST2, when acti-
vated in mitosis, phosphorylate MOBKL1A/MOBKL1B and
appear to be the kinases exclusively responsible for mitotic
MOBKL1A/MOBKL1B phosphorylation. Moreover elimination
of endogenous MOBKL1A/MOBKL1B, together with overex-
pression of a nonphosphorylatable MOBKL1A polypeptide,
exerts a stimulatory effect on cell proliferation by promoting
progression through several phases of the cell cycle. Although
eliminating MOBKL1A/MOBKL1B phosphorylation acceler-
ates cell proliferation by 2- to 3-fold (Figure 5B), cells lacking
phosphorylatable MOBKL1A/MOBKL1B are unaltered in their
distribution within the phases of the cell cycle, as compared
with cells expressing endogenous MOBKL1A/MOBKL1B or
overexpressed recombinant MOBKL1A (Figure 6A). An
increase in proliferative rate without a change in cell-cycle
distribution also was observed with Drosophila cells bearing
Hippo LOF mutations [11, 34]. This property suggests that
passage through more than one phase of the cell cycle is likely
to be enhanced by the elimination of MOBKL1A/MOBKL1B
phosphorylation, and the present data support this view.
Thus progression of cells through G1/S into G2/M is
accelerated by elimination of MOBKL1A phosphorylation
(Figure 6B); however, cells lacking MOBKL1A phosphorylation
do not accumulate in M, probably because exit from mitosis
also is accelerated (Figures 6C and 6D). The mechanism
underlying these actions of MOBKL1A/MOBKL1B phosphory-
lation remains to be determined. Although the effect of
MOBKL1 phosphorylation on G1/S progression is consistent
with the phenotype seen with Hippo LOF, the activity of
MST1 and MST2 and the levels of MOBKL1A/MOBKL1B phos-
phorylation in G1/S are very low as compared with those seen
in M, and the P-MOBKL1A/MOBKL1B target relevant to G1/S
progression is unknown. Whereas overexpression of wild-
type MOBKL1A, which undergoes a robust mitotic phosphor-
ylation (Figure 6A, left), substantially delays mitotic exit
(Figure 6C), it does not significantly alter proliferative rate
(Figure 5B, left) and has a minimal effect on progression
through G1/S (Figure 6B). Although it is possible that the
minimal levels of MST1/MST2 activity and MOBKL1 phosphor-
ylation in G1/S exert a nearly maximal inhibitory effect on
progression through this phase, it is more likely that as with
Hippo, active MST1/MST2 and P-MOBKL1 generated during
G2/M exert a more sustained transcriptional effect that is
responsible for the acceleration of G1/S. As for the role of
MOBKL1A/MOBKL1B in mitotic exit, although it is plausible
to infer that the inhibitory effect of MOBKL1A phosphorylation
is mediated by changes in the activity of LATS1, the evidence
on this point is not yet conclusive. Whereas overexpression ofMST(K56R) is sufficient to suppress H2O2-stimulated LATS1/
LATS2 phosphorylation at Thr1079 and Ser909 (Figure 3B), it
does not fully suppress the mitotic phosphorylation of
LATS1/LATS2 (Thr1079) or appreciably alter the mitotic phos-
phorylation of LATS1/LATS2 (Ser909), raising the possibility
that LATS1/LATS2 activity in mitosis is controlled by inputs
other than or in addition to MST1/MST2. Moreover, these
results raise the possibility that P-MOBKL1 targets other
than LATS1/LATS2 relevant to the control of cell proliferation
and mitotic exit remain to be identified.
Supplemental Data
Supplemental Experimental Procedures and five figures are available at
http://www.current-biology.com/cgi/content/full/18/5/311/DC1/.
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